SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-343711
Filing Date
2018-12-06
Accepted
2018-12-06 16:14:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d654950d424b5.htm 424B5 474011
2 GRAPHIC g654950g53t87.jpg GRAPHIC 32614
  Complete submission text file 0001193125-18-343711.txt   520082
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-220127 | Film No.: 181220803
SIC: 2834 Pharmaceutical Preparations